Thank you for your interest, we’ll get in touch with you shortly!

Du använder Internet Explorer, en webbläsare som slutade utvecklas 6 november 2013, för över 11 år sedan. Den 31 januari 2020 upphörde även alla säkerhetsuppdateringar vilket innebär att webbläsaren, förutom funktionella och utseendemässiga brister även kan utgöra en säkerhetsrisk. Du rekommenderas starkt att uppgradera till en modernare webbläsare, t ex Google Chrome, Mozilla Firefox eller Microsoft Edge. Tala med din systemadministratör.
Visa inte detta meddelande igen
Show filter

EMPOWERING HEALTHTECH CHANGE HOW THE WORLD CARES

HealthTech Nordic is a world leading community of healthtech companies. The member companies offer a variety of world class healthtech solutions which empower the individual, patients as well as professionals. It’s a paradigm shift, providing new and better ways of giving and receiving healthcare. Resulting in more health for the buck. We’re at the forefront of the digitalization of health and healthcare, and together, we can change how the world cares. 

We represent a fast-growing community consisting of companies from all over the world, improving the lives of millions, on every continent except Antarctica. 

➤ Use the search below to browse our member’s solutions.

Need help finding a solution meeting your needs or don’t know how to implement it? Let us help!

152 of 226

What are you looking for?

Preventing, diagnosing, treating or more efficiently addressing
  • Or specifically:
User
  • Or specifically:
Buyer
Country of origin
Visa Pharmista Technologies startup
Minimera kort Minimera kort

Pharmista Technologies

We at Pharmista Technologies are on a mission to disrupt the pregnancy testing market which has not been reinvented in over 30 years. To achieve this, we are developing a reusable pregnancy test that is based on a patented platform technology, enabling repeated detection of the target analyte. With 90% of women being interested in replacing todays solutions with our innovation, we are dedicated towards realising this product in the best possible way!

Key Benefits

  • Eliminates risk of miss-interpretation
  • Reusable 20 times minimum
  • 50% cheaper than competing alternatives
E-mail this to ...

Do you need more information about this company or have questions about how to implement the solution in your organization? Send us at HealthTech Nordic your e-mail address and we'll get back to you as soon as possible!

Pharmista Technologies

We at Pharmista Technologies are on a mission to disrupt the pregnancy testing market which has not been reinvented in over 30 years. To achieve this, we are developing a reusable pregnancy test that is based on a patented platform technology, enabling repeated detection of the target analyte. With 90 % of women being interested in replacing todays solutions with our innovation, we are dedicated towards realising this product in the best possible way!

Visa BordaTex startup
Minimera kort Minimera kort

BordaTex

BordaTex is a Stockholm based IoT company oriented towards the operational processes of healthcare. As BordaTex, our mission is to bring operational awareness and insight with actionable IoT data. Our solutions such as Asset Management, Patient Throughput, Infant Safety, Environmental Monitoring and Textile Tracking, enable data driven management and lead the way towards the era of insight driven management. Our hardware, middleware and software products offer an end-to-end solution.

E-mail this to ...

Do you need more information about this company or have questions about how to implement the solution in your organization? Send us at HealthTech Nordic your e-mail address and we'll get back to you as soon as possible!

BordaTex

BordaTex is a Stockholm based IoT company oriented towards the operational processes of healthcare. As BordaTex, our mission is to bring operational awareness and insight with actionable IoT data. Our solutions such as Asset Management, Patient Throughput, Infant Safety, Environmental Monitoring and Textile Tracking, enable data driven management and lead the way towards the era of insight driven management. Our hardware, middleware and software products offer an end-to-end solution.

Visa Second Opinion startup
Minimera kort Minimera kort

Second Opinion

Second Opinion is an AI-based software where the patient can seek a new medical second opinion from an independent doctor or specialist. This makes it possible to identify diagnostic errors and prevent harmful and unnecessary treatments for the patient. A second opinion contributes to an informed and empowered patient who is more involved in their healthcare journey.

Product in development
E-mail this to ...

Do you need more information about this company or have questions about how to implement the solution in your organization? Send us at HealthTech Nordic your e-mail address and we'll get back to you as soon as possible!

Second Opinion

Second Opinion is an AI-based software where the patient can seek a new medical second opinion from an independent doctor or specialist. This makes it possible to identify diagnostic errors and prevent harmful and unnecessary treatments for the patient. A second opinion contributes to an informed and empowered patient who is more involved in their healthcare journey.

Visa Mantis Photonics startup
Minimera kort Minimera kort

Mantis Photonics

Early screening is a major issue with alzheimer disease. Indeed, currently patients often get diagnosed too late, once they have cognitive impairment. As a result, treatments are less efficient and cannot repair the damage already caused by the disease. At Mantis Photonics, we have developed a patented hyperspectral camera that can detect biomarkers of alzheimer in the retina. This will be used as a non-invasive early detection tool for the screening of the population.

Product in development
E-mail this to ...

Do you need more information about this company or have questions about how to implement the solution in your organization? Send us at HealthTech Nordic your e-mail address and we'll get back to you as soon as possible!

Mantis Photonics

Early screening is a major issue with alzheimer disease. Indeed, currently patients often get diagnosed too late, once they have cognitive impairment. As a result, treatments are less efficient and cannot repair the damage already caused by the disease. At Mantis Photonics, we have developed a patented hyperspectral camera that can detect biomarkers of alzheimer in the retina. This will be used as a non-invasive early detection tool for the screening of the population.

Visa Rekonnect startup
Minimera kort Minimera kort

Rekonnect

Rekonnect is a B2B subscription platform that combines both product and user success for greater oversight of medical devices – so you can collaboratively improve your customer relationships. Our goal is to accelerate the adoption of innovative MedTech devices in healthcare systems around the world. Due to the disruptive changes in medical device regulation (MDR) MedTech companies must have greater oversight of devices deployed in the market, gather feedback from device users, and measure the impact on patient care. So we say ‘stop using workarounds, and start building medical device success.

Key Benefits

  • Sustainable training solutions, document traceability with change logs, accredited learning for product users, better post-market surveillance
E-mail this to ...

Do you need more information about this company or have questions about how to implement the solution in your organization? Send us at HealthTech Nordic your e-mail address and we'll get back to you as soon as possible!

Rekonnect

Rekonnect is a B2B subscription platform that combines both product and user success for greater oversight of medical devices - so you can collaboratively improve your customer relationships. Our goal is to accelerate the adoption of innovative MedTech devices in healthcare systems around the world. Due to the disruptive changes in medical device regulation (MDR) MedTech companies must have greater oversight of devices deployed in the market, gather feedback from device users, and measure the im

Visa Imvi labs startup
Minimera kort Minimera kort

Imvi labs

10% of the population can’t learn how to read due to a functional vision problem called vergence insufficiency, causing people to experience double vision, fatigue, and concentration issues reading. Improved vergence is essential to free up brain capacity to enable people with, e.g., dyslexia, to read better. Up to 50% of the population could significantly improve their reading performance with our patented VR-app. You can train on your smartphone wherever you are, whenever you want to.

Product on the market
E-mail this to ...

Do you need more information about this company or have questions about how to implement the solution in your organization? Send us at HealthTech Nordic your e-mail address and we'll get back to you as soon as possible!

Imvi labs

10% of the population can’t learn how to read due to a functional vision problem called vergence insufficiency, causing people to experience double vision, fatigue, and concentration issues reading. Improved vergence is essential to free up brain capacity to enable people with, e.g., dyslexia, to read better. Up to 50% of the population could significantly improve their reading performance with our patented VR-app. You can train on your smartphone wherever you are, whenever you want to.

Visa Njord Medtech startup
Minimera kort Minimera kort

Njord Medtech

Njord Medtech mission is to improve the quality of patient care and increAtle®180 is a motorized patient transfer device to improve work environment and productivity at hospitals, mainly targeted at Radiology department.

E-mail this to ...

Do you need more information about this company or have questions about how to implement the solution in your organization? Send us at HealthTech Nordic your e-mail address and we'll get back to you as soon as possible!

Njord Medtech

Atle®180 is a motorized patient transfer device to improve work environment and productivity at hospitals, mainly targeted at Radiology department.

Visa Intelligent Implants startup
Minimera kort Minimera kort

Intelligent Implants

Intelligent Implant develops the SmartFuse system a groundbreaking, first of its kind, smart orthopedic implant. It integrates the benefit of electrical stimulation, seamlessly incorporated into the interbody fusion device. It also incorporates non-invasive, remote monitoring of the bone formation.

E-mail this to ...

Do you need more information about this company or have questions about how to implement the solution in your organization? Send us at HealthTech Nordic your e-mail address and we'll get back to you as soon as possible!

Intelligent Implants

Intelligent Implant develops the SmartFuse system a groundbreaking, first of its kind, smart orthopedic implant. It integrates the benefit of electrical stimulation, seamlessly incorporated into the interbody fusion device. It also incorporates non-invasive, remote monitoring of the bone formation.

Visa Noui startup
Minimera kort Minimera kort

Noui

Noui is a tiny wearable bladder scanner to help the hospital staff to determine risk patients’ exact timing for catheterization or cystometry to minimise fatal cases, staffing hours and infection rates. We use electromagnetic communication, capacitance coupling method to compare the signal strengths and estimate fluidity of the bladder. It assists pharmaceutical companies to determine the time for dosing and new drug effectiveness for outpatients.

E-mail this to ...

Do you need more information about this company or have questions about how to implement the solution in your organization? Send us at HealthTech Nordic your e-mail address and we'll get back to you as soon as possible!

Noui

Noui is a tiny wearable bladder scanner to help the hospital staff to determine risk patients’ exact timing for catheterization or cystometry to minimise fatal cases, staffing hours and infection rates. We use electromagnetic communication, capacitance coupling method to compare the signal strengths and estimate fluidity of the bladder. It assists pharmaceutical companies to determine the time for dosing and new drug effectiveness for outpatients.